DISCOUNT ZERTIFIKAT - VERTEX PHARMACEUTICALS | Market Closed - Börse Stuttgart 03:12:47 2024-05-31 pm EDT | ||
| 307.8 EUR | +0.50% |
|
| Current month | +1.25% | ||
| 1 month | +1.25% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 307.8 | +0.50% |
| 24-05-30 | 306.3 | -0.42% |
| 24-05-29 | 307.6 | +0.28% |
| 24-05-28 | 306.7 | -0.36% |
| 24-05-27 | 307.8 | +0.05% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 03:12 pm EDT
More quotesStatic data
| Product type | Certificats Discount |
|---|---|
| Buy / Sell | CALL |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG1BT0 |
| ISIN | DE000MG1BT02 |
| Date issued | 2024-04-02 |
| Cap | 350 $ |
| Last trading day | 2025-03-21 |
| Maturity | 2025-03-21 (294 Days) |
| Parity | 1 : 1 |
| Emission price | 300.4 € |
| Emission volume | N/A |
| Payment day | 2025-03-28 |
| Bonus | - € |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Discount (ask) | 26.56 % |
|---|---|
| Sideways yield | 4.721 % |
| Sideways yield pa | 5.861 % |
| Outperformance point | 476.6 $ |
| Break even | 334.22 € |
| Highest since issue | 308.5 € |
| Lowest since issue | 295.7 € |
| Spread | 0.32 € |
| Spread % | 0.10% |
| Distance Cap | 105.3 $ |
| Distance Cap % | +23.13% |
| Max. earning | 14.55 |
| Max. earning % | 4.721 % |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
455.3
USD
Average target price
463.5
USD
Spread / Average Target
+1.80%
- Stock Market
- Certificates
- Certificat
